Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FATE | ABOS | SPRO | ||
| Company | Fate Therapeutics | Acumen Pharmaceuticals Inc | Spero Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.2200 | 2.48 | 2.30 | ||
| High | 1.2300 | 2.55 | 2.44 | ||
| Low | 1.1400 | 2.25 | 2.28 | ||
| Latest | 1.1700 | 2.26 | 2.33 | ||
| Change | -0.0600 | -0.29 | -0.04 | ||
| % Change | -4.88% | -11.37% | -1.69% | ||
| Volume | 1,168,600 | 924,500 | 498,700 | ||
| 20-Day Average Volume | 1,500,070 | 917,755 | 313,935 | ||
| Previous Close | 1.2300 | 2.55 | 2.37 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.2325 | 3.03 | 2.40 | ||
| 20-Day Raw Stochastic | 27.37% | 0.74% | 37.29% | ||
| 20-Day Relative Strength | 46.86 | 38.02 | 46.99 | ||
| Weighted Alpha | -5.93 | +53.84 | +3.68 | ||
| Today's Opinion | 8% Buy | 40% Buy | 24% Buy | ||
| Previous Opinion | 24% Buy | 56% Buy | 64% Buy | ||
| Last Month's Opinion | 72% Buy | 100% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.36% since 03/20/26 | -15.36% since 03/20/26 | -1.69% since 03/20/26 | ||
| Low | 1.1100 on 03/24/26 | 2.25 on 03/27/26 | 2.28 on 03/27/26 | ||
| High | 1.3100 on 03/26/26 | 2.81 on 03/23/26 | 2.48 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | -20.95% since 02/27/26 | -28.03% since 02/27/26 | +7.37% since 02/27/26 | ||
| Low | 1.0400 on 03/19/26 | 2.25 on 03/27/26 | 2.11 on 03/03/26 | ||
| High | 1.5150 on 03/02/26 | 3.60 on 03/16/26 | 2.70 on 03/17/26 | ||
| 3-Month | |||||
| %Chg | +17.00% since 12/26/25 | +7.11% since 12/26/25 | +0.43% since 12/26/25 | ||
| Low | 0.9632 on 12/30/25 | 1.67 on 01/12/26 | 2.10 on 02/03/26 | ||
| High | 1.6950 on 02/25/26 | 3.60 on 03/16/26 | 2.70 on 03/17/26 | ||
| 6-Month | |||||
| %Chg | +17.00% since 09/26/25 | +59.15% since 09/26/25 | +23.28% since 09/26/25 | ||
| Low | 0.9500 on 11/14/25 | 1.45 on 09/29/25 | 1.84 on 09/30/25 | ||
| High | 1.9399 on 10/27/25 | 3.60 on 03/16/26 | 2.75 on 11/12/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 136,028 | 136,895 | 131,270 | ||
| Shares Outstanding, K | 116,263 | 60,573 | 56,339 | ||
| Annual Sales | 6,650,000 | 0 | 47,980,000 | ||
| Annual Net Income | -136,320,000 | -102,330,000 | -68,570,000 | ||
| Last Quarter Sales | 1,370,000 | 0 | 5,440,000 | ||
| Last Quarter Net Income | -32,370,000 | -26,450,000 | -7,380,000 | ||
| 60-Month Beta | 2.19 | 0.21 | 1.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 02/26/26 | -0.44 on 11/12/25 | -0.13 on 11/13/25 | ||
| Latest Earnings Date | 05/12/26 | 05/12/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 09/16/15 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 19.75 | ||